Trial intelligence / Profile preview

Pharmacokinetics and EEG effects of kratom in healthy volunteers

TCTR20140729001Phase 1Completed

Sponsor
National Science and Technology Development Agency
Start
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, single-arm trial of ketum, sponsored by National Science and Technology Development Agency. Primary endpoints: Pharmacokinetic parameters of kratom and Effects of kratom on electroencephalogram (EEG). Started Jun 2014; status: completed.

02

Drugs

ketum

Beyond the preview

Go deeper on TCTR20140729001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20140729001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call